PortfoliosLab logoPortfoliosLab logo
CORT vs. POWL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CORT vs. POWL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Powell Industries, Inc. (POWL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CORT achieves a 174.02% return, which is significantly higher than POWL's 118.71% return. Over the past 10 years, CORT has underperformed POWL with an annualized return of 32.26%, while POWL has yielded a comparatively higher 37.59% annualized return.


CORT

1D
-1.34%
1M
16.92%
6M
116.83%
YTD
174.02%
1Y
41.09%
3Y*
57.58%
5Y*
36.28%
10Y*
32.26%
ALL TIME*
9.65%

POWL

1D
-4.23%
1M
-21.15%
6M
66.82%
YTD
118.71%
1Y
190.86%
3Y*
127.36%
5Y*
92.18%
10Y*
37.59%
ALL TIME*
14.34%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$110.38M$103.07M$82.67M
$185.18M$222.58M$206.91M

CORT vs. POWL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CORT
Corcept Therapeutics Incorporated
174.02%-30.94%55.14%59.92%2.58%-24.31%116.20%-9.43%-26.02%148.76%
POWL
Powell Industries, Inc.
118.71%44.49%152.21%155.62%24.34%3.60%-37.60%101.58%-9.92%-24.00%

Correlation

The correlation between CORT and POWL is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Apr 14, 2004

0.19

Fundamentals

Market Cap

CORT:

$10.24B

POWL:

$8.46B

EPS

CORT:

$0.42

POWL:

$5.12

PE Ratio

CORT:

229.57

POWL:

45.37

PEG Ratio

CORT:

114.36

POWL:

0.07

PS Ratio

CORT:

14.21

POWL:

7.49

PB Ratio

CORT:

15.61

POWL:

11.97

Total Revenue (TTM)

CORT:

$769.10M

POWL:

$1.13B

Gross Profit (TTM)

CORT:

$755.64M

POWL:

$340.78M

EBITDA (TTM)

CORT:

$3.66M

POWL:

$236.11M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CORT vs. POWL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT
CORT Risk / Return Rank: 6666
Overall Rank
CORT Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
CORT Sortino Ratio Rank: 6464
Sortino Ratio Rank
CORT Omega Ratio Rank: 7979
Omega Ratio Rank
CORT Calmar Ratio Rank: 6262
Calmar Ratio Rank
CORT Martin Ratio Rank: 6161
Martin Ratio Rank

POWL
POWL Risk / Return Rank: 9595
Overall Rank
POWL Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
POWL Sortino Ratio Rank: 9494
Sortino Ratio Rank
POWL Omega Ratio Rank: 9292
Omega Ratio Rank
POWL Calmar Ratio Rank: 9696
Calmar Ratio Rank
POWL Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CORT vs. POWL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Powell Industries, Inc. (POWL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CORTPOWLDifference
Sharpe ratioReturn per unit of total volatility

-2.60

Sortino ratioReturn per unit of downside risk

-2.15

Omega ratioGain probability vs. loss probability

1.24

1.40

-0.16

Calmar ratioReturn relative to maximum drawdown

0.64

6.22

-5.58

Martin ratioReturn relative to average drawdown

1.17

16.05

-14.88

CORT vs. POWL - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is 0.53, which is lower than the POWL Sharpe Ratio of 3.13. The chart below compares the historical Sharpe Ratios of CORT and POWL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CORT vs. POWL - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.29%, which is greater than POWL's maximum drawdown of -73.10%. Use the drawdown chart below to compare losses from any high point for CORT and POWL.


Loading charts...

Drawdown Indicators


CORTPOWLDifference

Max Drawdown

Largest peak-to-trough decline

-94.29%

-73.10%

-21.19%

Max Drawdown (1Y)

Largest decline over 1 year

-64.40%

-30.88%

-33.52%

Max Drawdown (3Y)

Largest decline over 3 years

-71.85%

-55.76%

-16.09%

Max Drawdown (5Y)

Largest decline over 5 years

-71.85%

-55.76%

-16.09%

Max Drawdown (10Y)

Largest decline over 10 years

-71.85%

-68.85%

-3.00%

Current Drawdown

Current decline from peak

-16.51%

-27.87%

+11.36%

Average Drawdown

Average peak-to-trough decline

-53.29%

-36.04%

-17.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.23%

11.94%

+23.29%

Volatility

CORT vs. POWL - Volatility Comparison

The current volatility for Corcept Therapeutics Incorporated (CORT) is 14.26%, while Powell Industries, Inc. (POWL) has a volatility of 20.55%. This indicates that CORT experiences smaller price fluctuations and is considered to be less risky than POWL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CORTPOWLDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.26%

20.55%

-6.29%

Volatility (6M)

Calculated over the trailing 6-month period

42.59%

47.50%

-4.91%

Volatility (1Y)

Calculated over the trailing 1-year period

77.23%

61.39%

+15.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.75%

64.94%

+9.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.26%

55.18%

+12.08%

Dividends

CORT vs. POWL - Dividend Comparison

CORT has not paid dividends to shareholders, while POWL's dividend yield for the trailing twelve months is around 0.15%.


PositionTTM20252024202320222021202020192018201720162015
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
POWL
Powell Industries, Inc.
0.15%0.34%0.48%1.19%2.96%3.53%3.53%2.12%4.16%3.63%2.67%4.00%

Financials

CORT vs. POWL - Financials Comparison

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Powell Industries, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M150.00M200.00M250.00M300.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
164.90M
296.62M
(CORT) Total Revenue
(POWL) Total Revenue
Values in USD except per share items

CORT vs. POWL - Profitability Comparison

The chart below illustrates the profitability comparison between Corcept Therapeutics Incorporated and Powell Industries, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
98.3%
29.7%
Portfolio components
CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.

POWL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Powell Industries, Inc. reported a gross profit of 87.94M and revenue of 296.62M. Therefore, the gross margin over that period was 29.7%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.

POWL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Powell Industries, Inc. reported an operating income of 57.58M and revenue of 296.62M, resulting in an operating margin of 19.4%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.

POWL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Powell Industries, Inc. reported a net income of 45.89M and revenue of 296.62M, resulting in a net margin of 15.5%.


Frequently Asked Questions


CORT and POWL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

POWL has higher volatility (20.55%) compared to CORT (14.26%). In terms of maximum drawdown, CORT dropped -94.29% vs POWL's -73.10%.

POWL currently has the higher Sharpe Ratio (3.13 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CORT and POWL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer